12 insiders reported 99 Form 4 transactions for Edgewise Therapeutics, Inc. (EWTX) over the past 18 months (most recent 2026-08-14). Recent activity: Derakhshan Behrad (Chief Business Officer) Buy 5,781 shares, MOORE JOHN R (General Counsel) Sell 59 shares, MOORE JOHN R (General Counsel) Buy 5,781 shares, Donovan Joanne M. (CMO) Buy 5,781 shares, KOCH KEVIN (President and CEO) Buy 17,969 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | Derakhshan Behrad | Chief Business Officer | Buy | 5,781 | $0 |
| 2026-08-14 | MOORE JOHN R | General Counsel | Sell | 59 | $2,620 |
| 2026-08-14 | MOORE JOHN R | General Counsel | Buy | 5,781 | $0 |
| 2026-08-14 | Donovan Joanne M. | CMO | Buy | 5,781 | $0 |
| 2026-08-14 | KOCH KEVIN | President and CEO | Buy | 17,969 | $0 |
| 2026-08-14 | Russell Alan J | Chief Scientific Officer | Buy | 7,031 | $0 |
| 2026-08-14 | MOORE JOHN R | General Counsel | Buy | 6,718 | $0 |
| 2026-08-14 | Russell Alan J | Chief Scientific Officer | Buy | 5,781 | $0 |
| 2026-08-14 | Derakhshan Behrad | Chief Business Officer | Buy | 7,500 | $0 |
| 2026-08-14 | Donovan Joanne M. | CMO | Buy | 7,031 | $0 |
| 2026-08-14 | Russell Alan J | Chief Scientific Officer | Sell | 3,238 | $141,428 |
| 2026-08-14 | KOCH KEVIN | President and CEO | Sell | 8,782 | $383,254 |
| 2026-08-14 | MOORE JOHN R | General Counsel | Sell | 2,439 | $106,848 |
| 2026-08-14 | Derakhshan Behrad | Chief Business Officer | Sell | 2,171 | $95,075 |
| 2026-08-14 | Donovan Joanne M. | CMO | Sell | 2,839 | $124,303 |
| 2026-08-14 | Donovan Joanne M. | CMO | Sell | 2,779 | $121,463 |
| 2026-08-14 | Derakhshan Behrad | Chief Business Officer | Sell | 304 | $13,529 |
| 2026-08-14 | KOCH KEVIN | President and CEO | Sell | 8,276 | $361,315 |
| 2026-08-14 | Russell Alan J | Chief Scientific Officer | Sell | 2,273 | $99,275 |
| 2026-08-14 | Derakhshan Behrad | Chief Business Officer | Sell | 150 | $6,666 |
| 2026-08-14 | Donovan Joanne M. | CMO | Sell | 104 | $4,620 |
| 2026-08-14 | MOORE JOHN R | General Counsel | Sell | 99 | $4,406 |
| 2026-08-14 | Russell Alan J | Chief Scientific Officer | Sell | 390 | $17,339 |
| 2026-08-14 | KOCH KEVIN | President and CEO | Sell | 913 | $40,473 |
| 2026-08-14 | KOCH KEVIN | President and CEO | Buy | 21,875 | $0 |
Source: SEC Form 4 filings · as of 2026-08-14